호르몬 대체 요법 시장 성장, 규모, 점유율, 추세, 주요 업체 분석 및 2031년까지 예측

  • Report Code : TIPRE00003836
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Hormone Replacement Therapy Market Share and Growth | 2031

Buy Now

호르몬 대체 요법 시장 예측은 이 시장의 이해관계자들이 성장 전략을 수립하는 데 도움이 될 수 있습니다. 시장은 2023년 미화 84억 6,000만 달러에서 2031년에는 미화 148억 2,000만 달러로 성장할 것으로 예상됩니다. 2023~2031년 연평균 성장률(CAGR)은 7.3%를 기록할 것으로 추정됩니다.

호르몬 대체 요법(HRT)에 대한 전 세계 수요는 다음과 같은 요인으로 인해 꾸준히 증가하고 있습니다. 호르몬 장애의 유병률 증가, 호르몬 결핍에 대한 인식 증가, HRT 제제의 개선. 명백한 안전성과 효과성 이점으로 인해 생체 동일 호르몬 대체 요법(BHRT)이 합성 호르몬보다 더 인기를 얻고 있습니다. BHRT는 천연 공급원에서 나오므로 신체가 자연적으로 생성하는 호르몬과 더 유사하다고 생각됩니다.

제약회사에서는 다음을 포함하여 새로운 호르몬 치료법 개발에 투자하고 있습니다. 경피 패치, 젤, 크림 및 피하 임플란트를 통해 환자 편의성, 순응도 및 안전성 프로필을 개선합니다. 이 요인은 호르몬 대체 요법시장 성장을 촉진합니다. 2023년 8월 미국 식품의약국(FDA)은 ANI Pharmaceuticals의 0.1% 에스트라디올 겔에 대한 약식 신약 신청을 승인했습니다. 참고문헌에 등재된 약물인 디비젤(Divigel)은 폐경기와 관련된 중등도에서 중증의 혈관 운동 증상을 치료하는 데 사용되는 에스트로겐 호르몬 요법입니다. Divigel의 일반적인 형태는 에스트라디올 젤, 0.1%입니다.

성장 동인:

다양한 응용 분야로 호르몬 대체 요법 시장 성장 촉진

호르몬 대체 요법은 폐경기 증상, 성장 호르몬 치료를 위해 처방됩니다. 결핍 등은 개인의 삶에 심각한 영향을 미칠 수 있습니다. 수백만 명의 여성이 때로는 장기간 HRT를 사용합니다. HRT는 다양한 방법으로 골다공증을 예방하고 삶의 질을 향상시킬 수 있습니다. Oregon Health & 사이언스 대학교(Science University)의 성장 호르몬 결핍증(GHD)은 흔하지 않으며 미국 내 성인 약 50,000명, 어린이 약 4,000~6,000명 중 1명에게 영향을 미칩니다. 따라서 다양한 호르몬 장애의 유병률 증가와 함께 치료법 사용 증가는 호르몬 대체 요법 시장 성장을 촉진합니다.

제한:

u>

높은 약물 비용으로 인해 호르몬 대체 요법 시장 성장이 저해됨

< 스팬>HRT 제품의 가격은 상대적으로 높습니다. 예를 들어, 폐경 센터(The Menopause Center)에 따르면 경구 호르몬 대체 요법 처방 가격은 월 US$ 130~US$ 240(즉, 연간 US$ 1,560~US$ 2,440)입니다. 높은 비용으로 인해 이러한 제품의 정기적인 사용이 금지되어 호르몬 대체 요법 시장의 성장이 억제됩니다.

보고서 세분화 및 범위:

호르몬 대체 요법 시장 분석은 치료, 적용, 투여 경로 및 최종 사용자 부문을 고려하여 수행되었습니다.

< p>호르몬 대체 요법 시장은 치료법에 따라 에스트로겐 호르몬 대체, 성장 호르몬 대체, 갑상선 호르몬 대체, 테스토스테론 대체 등으로 분류됩니다. 에스트로겐 호르몬 대체 요법 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.

호르몬 대체 요법 시장은 용도별, 폐경, 성장호르몬(GH) 결핍, 갑상선 기능 저하증, 성선 기능 저하증 등으로 분류됩니다. 폐경 부문은 2023년에 가장 큰 호르몬 대체 요법 시장 점유율을 차지했으며 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

지역 분석:

지역 측면에서 호르몬 대체 요법 시장 보고서의 범위에는 다음이 포함됩니다. 북미, 유럽, 아시아 태평양, 남부 & 중앙아메리카, 중동 & 아프리카. 2023년에는 북미가 가장 큰 시장 점유율을 차지했습니다. 최신 기술의 채택 증가, 호르몬 장애 유병률 증가, 신제품의 조기 채택, 주요 시장 참여자의 존재로 인해 북미 지역에서 호르몬 대체 요법 시장 규모가 급증하고 있습니다. 2023년 6월, 주 1회 투여하는 인간 성장호르몬 유사체인 NGENLA(소마트로곤글라)는 부족으로 인한 성장부전을 겪는 3세 이상의 소아 환자 치료에 사용하도록 미국 식품의약국(FDA)으로부터 승인을 받았습니다. Pfizer Inc.와 OPKO Health Inc.가 발표한 성명에 따르면 내인성 성장 호르몬 분비가 증가한다고 합니다.

또한, 고품질 맞춤형 치료에 대한 접근성을 제공하고 의료 솔루션은 예측 기간 동안 호르몬 대체 요법 시장에 상당한 기회를 창출할 것입니다. 2023년 5월, 텍사스 최대 호르몬 대체 클리닉 네트워크 중 하나인 Hormones by Design이 통합 및 기능 의학 제공업체의 최초 전국 네트워크인 Forum Health, LLC에 인수되었습니다.

산업 발전 및 미래 기회:

호르몬 대체 요법 시장에서 활동하는 선두 기업의 전략적 발전 , 회사 보도 자료에 따르면 다음과 같습니다.

    2024년 1월 덴마크의 Ascendis Pharma A/S와 Vector Pharma FZCO( 벡터)는 사우디아라비아, UAE, 쿠웨이트, 오만, 카타르, 바레인 등 걸프협력회의(GCC) 국가에서 요르비패스(Yorvipath)와 스카이트로파(Skytrofa) 상용화를 위한 독점 유통 계약을 체결했다. 본 독점 유통 계약의 조건에 따라 벡터는 판매 및 마케팅 경험을 활용하여 GCC 국가의 환자에게 요르비패스(Yorvipath) 및 소아 성장 호르몬 결핍증(GHD)의 경우 성인 부갑상선 기능 저하증 치료를 위한 요르비패스(Yorvipath) 및 스카이트로파(Skytrofa)를 제공할 것입니다. Skytrofa의 사례.

Co경쟁력 있는 환경 및 주요 회사:< /strong>

아스트라제네카; 화이자 주식회사; 노바티스 AG; 애보트; 톨마 주식회사; 파제약; Mayne Pharma Group Limited; 노보 노르디스크 A/S; 엘리 릴리 앤 컴퍼니; 및 Noven Pharmaceuticals, Inc.는 호르몬 대체 요법 시장 보고서에 소개된 주요 기업 중 하나입니다. 이들 회사는 전 세계적으로 증가하는 소비자 수요를 충족하기 위해 새로운 기술을 개발하고, 기존 제품을 업그레이드하고, 지리적 입지를 확장하는 데 중점을 두고 있습니다.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which therapy segment dominates the hormone replacement therapy market?

By therapy, the market is segmented into estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, testosterone replacement, and others. The estrogen hormone replacement segment held a larger hormone replacement therapy market share in 2023.

What factors drive the hormone replacement therapy market?

Increasing use of hormone replacement therapy products and increasing prevalence of hormone disorder propel the hormone replacement therapy market growth. However, high cost of medications hampers the growth of the market.

Who are the major players in the hormone replacement therapy market?

The hormone replacement therapy market majorly consists of the players, including Astrazeneca, Pfizer Inc., Novartis AG, Abbott, Tolmar Inc, Par Pharmaceutical, Mayne Pharma Group Limited, Novo Nordisk A/S, Eli Lily And Company, and Noven Pharmaceuticals, Inc.

What is hormone replacement therapy?

Medication that contains female hormones is known as hormone replacement treatment. When you go through menopause, your body stops producing estrogen, so you take medication to replace it. The most common menopausal symptoms that hormone therapy is used to treat are hot flashes and vaginal discomfort.

Which application segment dominates the hormone replacement therapy market?

The market, by distribution channel, is categorized into menopause, growth hormone (GH) deficiency, hypothyroidism, hypogonadism, and others. The menopause segment held the largest menopause market share in 2023, and it is anticipated to register the highest CAGR during the forecast period.

What are the growth estimates for the hormone replacement therapy market till 2031?

The hormone replacement therapy market is expected to be valued at US$ 14.82 billion in 2031.

What was the estimated hormone replacement therapy market size in 2023?

The hormone replacement therapy market was valued at US$ 8.46 billion in 2023.

The List of Companies - Hormone Replacement Therapy Market

  1. Astrazeneca
  2. Pfizer Inc.
  3. Novartis AG
  4. Abbott
  5. Tolmar Inc
  6. Par Pharmaceutical
  7. Mayne Pharma Group Limited
  8. Novo Nordisk A/S
  9. Eli Lily And Company
  10. Noven Pharmaceuticals, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..